Terms: = Pancreatic cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
123 results:
1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
Urganci N; Kepil N; Ergun S; Bakkaloglu OK
J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
J Gastroenterol; 2024 Feb; 59(2):145-156. PubMed ID: 38006445
[TBL] [Abstract] [Full Text] [Related]
3. Association of Glycated Hemoglobin With a Risk of pancreatic cancer in High-Risk Individuals Based on Genetic and Family History.
Wu BU; Chen Q; Moon BH; Lustigova E; Nielsen EG; Alvarado M; Ahmed SA
Clin Transl Gastroenterol; 2024 Jan; 15(1):e00650. PubMed ID: 37800692
[TBL] [Abstract] [Full Text] [Related]
4. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing pancreatic cancer Surveillance.
Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
[TBL] [Abstract] [Full Text] [Related]
5. Risk of Syndrome-Associated cancers Among First-Degree Relatives of Patients With pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract] [Full Text] [Related]
6. Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas.
Pea A; Paolino G; Martelli F; Bariani E; Piccoli P; Sereni E; Salvia R; Lawlor RT; Cheng L; Chang D; Scarpa A; Luchini C
Virchows Arch; 2023 Aug; 483(2):157-165. PubMed ID: 37086293
[TBL] [Abstract] [Full Text] [Related]
7. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
Roch AM; Kim RC; Nguyen TK; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
J Surg Oncol; 2023 Aug; 128(2):289-294. PubMed ID: 37083062
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
Aronson M; Gryfe R; Choi YH; Semotiuk K; Holter S; Ward T; Gallinger S; Cohen Z; Briollais L
J Natl Cancer Inst; 2023 Jul; 115(7):778-787. PubMed ID: 36964717
[TBL] [Abstract] [Full Text] [Related]
9. Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
Cerrato C; Pandolfo SD; Autorino R; Panunzio A; Tafuri A; Porcaro AB; Veccia A; De Marco V; Cerruto MA; Antonelli A; Derweesh IH; Maresma MCM
World J Urol; 2023 Jul; 41(7):1741-1749. PubMed ID: 36964236
[TBL] [Abstract] [Full Text] [Related]
10. Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
Fujitani H; Eguchi H; Kochi Y; Arai T; Muramatsu M; Okazaki Y
Eur J Cancer Prev; 2023 May; 32(3):286-297. PubMed ID: 36896836
[TBL] [Abstract] [Full Text] [Related]
11. A novel germline SMAD4 variant detected in a Japanese family with juvenile polyposis syndrome and hereditary hemorrhagic telangiectasia.
Kananazawa Y; Yamada T; Yamaguchi T; Saito Y; Kakinuma D; Masuda Y; Ando F; Ohashi R; Eguchi H; Okazaki Y; Ishida H; Yoshida H
Jpn J Clin Oncol; 2023 Mar; 53(3):275-279. PubMed ID: 36546711
[TBL] [Abstract] [Full Text] [Related]
12. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
Bennett C; Suguitan M; Abad J; Chawla A
Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
[TBL] [Abstract] [Full Text] [Related]
13. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications.
Ban X; Mo S; Lu Z; Jia C; Shao H; Chang X; Mao X; Zhang Y; Pang J; Zhang Y; Yu S; Chen J
Endocrine; 2022 Sep; 77(3):538-545. PubMed ID: 35708896
[TBL] [Abstract] [Full Text] [Related]
14. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis.
Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
[TBL] [Abstract] [Full Text] [Related]
15. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
[TBL] [Abstract] [Full Text] [Related]
16. pancreatic Ductal Carcinoma Risk Associated With Hereditary cancer-Risk Genes.
Gardiner A; Kidd J; Elias MC; Young K; Mabey B; Taherian N; Cummings S; Malafa M; Rosenthal E; Permuth JB
J Natl Cancer Inst; 2022 Jul; 114(7):996-1002. PubMed ID: 35445726
[TBL] [Abstract] [Full Text] [Related]
17. A morphological and immunohistochemical study of the endoscopic ultrasound-fine-needle biopsy samples from solid pancreatic masses: a single center study.
Constantinescu A; Ilie-Stan CM; Şandru V; Ungureanu BS; Gheonea DI; Ciurea T; Plotogea OM; Pavel C; Enache V; Munteanu MA; Constantinescu G
Rom J Morphol Embryol; 2021; 62(3):723-731. PubMed ID: 35263400
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Features and Clinical Management of Hereditary pancreatic cancer Syndromes and Familial pancreatic cancer.
Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129
[TBL] [Abstract] [Full Text] [Related]
20. pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of msh2 and MSH6 expression: a case report.
Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N
Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278
[TBL] [Abstract] [Full Text] [Related]
[Next]